Home >
Medicine Info >
Restasis 0.05 % Eye Drops
Loading interface...

Restasis 0.05 % Eye Drops

Manufactured byAllergan India Ltd.
ContainsCyclosporine
Description
Restasis 0.05 % Eye Drops is a medicine that contains Cyclosporine. It is used in the treatment of dry eyes (an eye condition that occurs when the eyes do not produce enough tears or when the tears evaporate too quickly). This medicine works by decreasing the swelling in your eyes which helps in improving tear production and provides relief from discomfort in the eyes. Restasis 0.05 % Eye Drops may cause side effects such as pain, redness, itching, irritation of your eyes, blurred vision, watery eyes, etc. These symptoms usually subside on their own. However, consult your doctor if these symptoms persist for a long time or worsen. Avoid driving vehicles or operating machines if you experience these symptoms after using this medicine. Restasis 0.05 % Eye Drops should be used as prescribed by your doctor. Consult your doctor if you use contact lenses. Inform your doctor if you develop an eye infection while using this medicine. Restasis 0.05 % Eye Drops is not recommended if you are allergic to it. Inform your doctor if you are using any other eye drops to avoid undesired side effects. This medicine is not recommended in children below 18 years of age. If you are pregnant, breastfeeding, or planning a pregnancy, consult your doctor before using this medication.
QUICK LINKS:
Side effectsConcernsUsageRelated products

Substitutes

List of substitutes for Restasis 0.05 % Eye Drops

Cyclodrop 0.05 % Eye Drops
Zydus Cadila
Cyclomune 0.05 % Eye Drops
Sun Pharma Laboratories Ltd.
Iflo 0.05 % Eye Drops
Ajanta Pharma Ltd.
Imudrops 0.05 % Eye Drops
Cipla Ltd.
IMUDROPS EYE DROPS
Cipla Ltd.

Side effects

Major & minor side effects for Restasis 0.05 % Eye Drops

  • Eye pain
  • Eye irritation
  • Redness and swelling of the eyelid
  • Watery eyes
  • Blurred vision
  • Redness and itching of the eye

Uses of Restasis 0.05 % Eye Drops

What is it prescribed for?

  • Keratoconjunctivitis Sicca (Dry eye syndrome)
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The time required by Restasis 0.05 % Eye Drops to start showing its effect is not known.
  • How long do the effects of this medicine last?
    The duration for which Restasis 0.05 % Eye Drops remains effective is not known.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies have been reported with Restasis 0.05 % Eye Drops.
  • Can this medicine be taken during pregnancy?
    Restasis 0.05 % Eye Drops is not recommended for use in pregnancy as it may cause side effects in your developing foetus. Hence, if you are pregnant, consult your doctor before using this medicine.
  • Can this medicine be taken while breast-feeding?
    It is not known if Restasis 0.05 % Eye Drops passes into breastmilk. Hence, this medicine is not recommended during breastfeeding. If you are breastfeeding, consult your doctor before using this medicine.

Allergy

Avoid using Restasis 0.05 % Eye Drops if you are allergic to this medicine. Seek immediate medical attention if you notice any allergic symptoms such as skin rash, redness and/or itching, sneezing, breathing difficulty, etc., after using this medicine.

Ocular or Periocular malignancies

Ocular malignancies are cancers that occur inside your eye, whereas, periocular malignancies are cancers that occur around the surface of your eye. Restasis 0.05 % Eye Drops is not recommended for use if you have a history of cancer or active cancer in or around your eye.

Ocular or Periocular infections

Ocular and Periocular infections are eye infections that occur inside your eye and around your eye respectively. Restasis 0.05 % Eye Drops is not recommended for use if you have an eye infection, due to the increased risk of worsening your condition.
Warnings for special population

Pregnancy

Restasis 0.05 % Eye Drops is not recommended for use in pregnancy as it may cause side effects in your developing foetus. Hence, if you are pregnant, consult your doctor before using this medicine.

Breast-feeding

It is not known if Restasis 0.05 % Eye Drops passes into breastmilk. Hence, this medicine is not recommended during breastfeeding. If you are breastfeeding, consult your doctor before using this medicine.
General warnings

Contact lens

Do not wear contact lenses if you experience dryness in your eyes. Restasis 0.05 % Eye Drops should not be used if you are using contact lenses. Consult your doctor regarding the use of contact lenses while on treatment with this medicine.

Driving or operating machines

Restasis 0.05 % Eye Drops may cause blurred vision or discomfort in your eyes (redness/itching/swelling, etc.). If you experience such symptoms after using this medicine, avoid driving vehicles or operating machines until your vision is clear.

Use in children

Restasis 0.05 % Eye Drops is not recommended for use in children below 18 years of age due to a lack of safety and efficacy data.

Other medicines

Inform your doctor if you are using any other eye drops before beginning treatment with Restasis 0.05 % Eye Drops, as this medicine may interact with them and increase the risk of serious side effects.

Infections

Restasis 0.05 % Eye Drops may increase the risk of infections. Therefore, a regular eye examination is recommended (at least every six months), when this medicine is indicated for long-term use.

Missed Dose

Do not skip any dose of Restasis 0.05 % Eye Drops. Instil the missed dose as soon as you remember. If it is time for your next dose, skip the missed dose. Do not double your dose to compensate for the missed one.

Overdose

Never instil more than the prescribed dose. If you suspect that you might have instilled an overdose of Restasis 0.05 % Eye Drops, seek immediate medical help.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine
Disease interactions

Disease

Information not available.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Restasis 0.05 % Eye Drops is meant for ophthalmic use only. Use this medicine as instructed by your doctor. Avoid touching the tip of the dropper against your eye or other surfaces. Close the lid of the dropper after each use to keep it clean and free from contamination. Do not wipe or rinse the dropper tip. Use Restasis 0.05 % Eye Drops at around the same time daily for the ease of remembering. Do not discontinue the use of this medicine without consulting your doctor. Do not give Restasis 0.05 % Eye Drops to others even if their condition appears to be the same as yours. Keep the medicine away from the reach of children and pets. Ensure that the unused medicine is disposed of properly.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Does not cause sleepiness

How it works
Restasis 0.05 % Eye Drops works by decreasing the swelling in your eyes. It helps in improving tear production and provides relief from discomfort in the eyes.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Ophthalmic anti-inflammatory agents

Schedule

Schedule H

Medicines.org.uk. 2021. IKERVIS 1 mg/mL eye drops, emulsion - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: < [Accessed 25 October 2021].

https://www.medicines.org.uk/emc/product/6937/smpc>

Medicines.org.uk. 2021. [online] Available at: < [Accessed 25 October 2021].

https://www.medicines.org.uk/emc/files/pil.6937.pdf>

Pubchem.ncbi.nlm.nih.gov. 2021. Cyclosporin A. [online] Available at: < [Accessed 25 October 2021].

https://pubchem.ncbi.nlm.nih.gov/compound/Cyclosporin-A>

Drugs, H., 2021. Cyclosporine Ophthalmic: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: < [Accessed 25 October 2021].

https://medlineplus.gov/druginfo/meds/a604009.html>

Accessdata.fda.gov. 2021. [online] Available at: < [Accessed 25 October 2021].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050790s020lbl.pdf>

Ebs.tga.gov.au. 2021. TGA eBS - Product and Consumer Medicine Information Licence. [online] Available at: < [Accessed 25 October 2021].

https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-PI-02691-1&d=20211025172310101>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 5 Jan 2022

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.